Denali Therapeutics
This role involves leading and mentoring the Oligonucleotide & Small Molecule CMC Analytical Development team while providing hands-on scientific leadership in analytical method development, testing, and characterization. The position oversees laboratory capabilities, external analytical work, and regulatory documentation to advance development programs for neurodegenerative diseases and other serious conditions. The role requires collaboration across cross-functional teams to resolve technical challenges and meet program goals.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2015
Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. We discover, develop and deliver medicines for people living with serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Denali Therapeutics.